New Software Features Increased System Up-Time and Improved Overall
TARRYTOWN, N.Y., Oct. 2 /PRNewswire-FirstCall/ -- Siemens Medical Solutions Diagnostics (http://www.siemens.com/diagnostics) announced today worldwide availability of version 2.0 software for the Rapidlab 1200(R) Series Blood Gas System. The new software will be a required upgrade for all existing customers and included on all Rapidlab 1200 systems in the future.
Designed specifically for the critical care laboratory, the Rapidlab 1200 system provides high test accuracy and comprehensive test menus including blood gas, electrolytes, metabolites and full CO-oximetry with rapid delivery of results. The Version 2.0 software continues to build on the performance and proven technology of the Rapidlab 1200 system by adding many new capabilities that can enhance patient care, including fully customizable panels for ease- of-use with frequently run profiles. Also, quality control (QC) performance is monitored and tracked through extensive QC routines that have been added to the Rapidlab 1200 base unit software to facilitate regulatory compliance.
In addition, on-line troubleshooting guidance helps to pinpoint and resolve fluidic difficulties quickly and when coupled with the improvements to the calibration sequences, the analyzer is in the 'ready' state to deliver patient results as quickly and accurately as possible.
"In the critical care environment, immediate access to crucial patient results is essential to making quality therapeutic decisions," said Arnd Kaldowski, senior vice president, Point of Care Business, Siemens Medical Solutions Diagnostics. "This new version 2.0 software adds new capabilities to the Rapidlab 1200 system, enabling our customers to operate their Blood Gas diagnosis even more effectively. With this new release the strong performance of the Rapidlab 1200 platform, offering a blood gas system that delivers fast, reliable patient results that meet the demands of today's laboratory, is elevated even further."
Siemens continues its commitment to deliver innovative, high-quality systems in an effort to offer physicians real-time access to the oxygenation status of their critically ill patients, enabling more precise therapeutic management decisions and better patient care. Siemens offers a comprehensive line of critical care testing products that meet the testing needs of both the laboratory and the point of care site, designed for efficiency and value to deliver the right patient information to the right location at the right time to help improve patient outcomes.
About Siemens Medical Solutions Diagnostics
Siemens Medical Solutions Diagnostics offers a broad portfolio of performance-driven diagnostic solutions that assist in the diagnosis, monitoring and management of disease. Products and services bring together the right balance of science, technology, and practicality across the healthcare continuum to empower medical professionals with the vital information they need to deliver better, more personalized healthcare to patients around the globe. Visit http://www.siemens.com/diagnostics.
About Siemens Medical Solutions
Siemens Medical Solutions of Siemens AG (NYSE: SI) is one of the world's largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services, to help customers achieve tangible, sustainable, clinical and financial outcomes. Recent acquisitions in the area of in-vitro diagnostics - such as Diagnostic Products Corporation and Bayer Diagnostics - mark a significant milestone for Siemens as it becomes the first full service diagnostics company. Employing more than 41,000 people worldwide and operating in over 130 countries, Siemens Medical Solutions reported sales of 8.23 billion EUR, orders of 9.33 billion EUR and group profit of 1.06 billion EUR for fiscal 2006 (Sept. 30). Further information can be found by visiting http://www.usa.siemens.com/medical-pressroom.
|SOURCE Siemens Medical Solutions Diagnostics|
Copyright©2007 PR Newswire.
All rights reserved